Javara today has emerged as the latest company to take on the clinical trials industry – though backed by a group of industry veterans, it is not a startup, and its goals not short of transformational.
This year’s DIA Global Annual Meeting will focus on the latest global trends and showcase the "diverse group of key individuals driving the life science ecosystem forward," says DIA Americas managing director.